Immun’Âge® Granted Japanese Patent Recognizing Activation of Nrf2, the Body’s Master Cellular Defense Pathway

Backed by more than 30 peer-reviewed human clinical studies supporting endogenous antioxidant activity, cellular ...
MyChesCo on MSN

CRISPR breakthrough reverses chemo resistance in aggressive cancers

NEWARK, DE — New preclinical research from CorriXR Therapeutics suggests a novel gene-editing strategy could reopen the door ...

CorriXR Therapeutics Announces Publication of Additional Preclinical Data Corroborating Ability of NRF2 Knockout to Restore Chemosensitivity in Solid Tumors

A new publication from CorriXR Therapeutics, an oncology focused biotherapeutics company developing genetic medicines to overcome drug resistance in solid tumors, shows that its novel CRISPR-directed ...
JSTOR Daily

Mild heat shock at 40 °C increases levels of autophagy: Role of Nrf2

The exposure to low doses of stress induces an adaptive survival response that involves the upregulation of cellular defense systems such as heat shock proteins (Hsps), anti-apoptosis proteins, and ...
BioWorld

Shanghai Institute of Organic Chemistry discovers new KEAP1/NRF2/ARE pathway activators

Shanghai Institute of Organic Chemistry has described oleanamide derivatives acting as Kelch-like ECH-associated protein 1 (KEAP1)/nuclear factor erythroid 2-related factor 2 (NFE2-related factor 2; ...